Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > NEW AUGUST 2020 PRESENTATION POSTED
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(105)
•••
Comment by Schaffhausenon Aug 23, 2020 9:59am
231 Views
Post# 31443050

RE:NEW AUGUST 2020 PRESENTATION POSTED

RE:NEW AUGUST 2020 PRESENTATION POSTED
Like I have reported myself, VIVO has the lowest ratio of Enterprise Value versus Revenue in its peer group. The EV/rev of VIVO is actually magnitudes better than the big LPs that are not considered peers (ie. Canopy). So, like I have said before, investors looking to make the mega-growth cannabis sector a part of their portfolio must consider VIVO as their instrument to capitalize big time versus considering any peers or large cap LPS. The currently low VIVO SP will disappear soon enough. This will be a 4 bagger in no time. Cheers Schaff
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities